Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
333
NCT02947867
Trial of Aganirsen in iCRVO Patients at Risk of Developing NVG
Phase: Phase 2/3
Role: Lead Sponsor
Start: Jan 31, 2017
Completion: Dec 31, 2019